Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

EveryCat Health Foundation's Support of the University of Missouri's 99 Lives Cat Genome Sequencing Initiative is Saving Feline Lives, Creating Global Access to Research


News provided by

EveryCat Health Foundation

May 19, 2026, 07:12 ET

Share this article

Share toX

Share this article

Share toX


The 99 Lives Cat Genome Sequencing Initiative has achieved major scientific milestones by creating 1,000+ cat datasets

WYCKOFF, N.J., May 19, 2026 /PRNewswire-PRWeb/ -- EveryCat Health Foundation, the world's leading granting foundation solely focused on advancing feline health through the funding of impactful scientific research, has contributed to genomic research by the University of Missouri College of Veterinary Medicine's 99 Lives Cat Genome Sequencing Initiative, with groundbreaking results. The 99 Lives initiative is led by Dr. Leslie A. Lyons and has completed genomic sequencing that has identified several feline diseases, saving feline lives and transforming access to life-saving research by making its data available to researchers via an open-source platform.

"We're excited about the work 99 Lives is doing and the positive impact it has on the health of both cats and humans," said Jackie Ott Jaakola, President and CEO, EveryCat Health Foundation. "Not only can we save cats one genome at a time, but the research we fund in support of 99 Lives can also help people, as some of the findings are translational to human health conditions."

"We're excited about the work 99 Lives is doing and the positive impact it has on the health of both cats and humans," said Jackie Ott Jaakola, President and CEO, EveryCat Health Foundation.

Post this

99 Lives Cat Genome Sequencing Initiative: Gold Standard and Global Resource

The 99 Lives Cat Genome Sequencing Project is a global feline research community that has developed a database of normal and abnormal genetic variations of domestic cats. Since 2013, the group has successfully produced, collated, and analyzed the genome sequences of over 1,000 cats, with assistance from about 40 collaborators—including members of the veterinary and genetics communities, the pet food industry, and private cat owners. The work of this collaborative has led to a dataset that includes 50 cat breeds, as well as hybrid and mixed-breed cats.

"Our work has become a global resource for gold standard sequence testing and the creation of a readily available science information resource," said Dr. Leslie A. Lyons, Director, 99 Lives Cat Genome Sequencing Initiative and Gilbreath-McLorn Endowed Professor of Comparative Medicine, Department of Veterinary Medicine & Surgery. "It's a collaboration between vets all over the world and our research lab—with EveryCat Health Foundation supporting our efforts every step of the way."

Lyons and her team of collaborators have produced about 25 percent of the genome sequences included in the project. Their work culminated in the Feline Genetics and Comparative Medicine Laboratory identifying 60 DNA variants for diseases and traits, almost 30 percent of all known cat DNA variants, including those variants associated with diseases such as polycystic kidney disease, Ehlers-Danlos Syndrome, muscular dystrophies, and retinal degenerations. Also, her work has led to the identification of several cat traits like rexoid fur coats, dwarfism, and cat coat colors.

Supporting a Critical Milestone: Creation of 1,000+ Cat Genome Data Sets

EveryCat Health Foundation has invested nearly $300,000 in this particular initiative —made possible through the sustained generosity of many donors over the years, including recent support from the Doris Day and Terry Melcher Foundation.

The cost of this process has decreased significantly in recent years, allowing the group to ramp up its research and achieve a major scientific milestone: creating 1,000 cat datasets. Studies use cats' DNA to predict several diseases in specific breeds and in random-breed cats. For example, 99 Lives identified the genome sequencing for spasticity, a genetic disorder found in Sphynx and Devon Rex cats.

About the University of Missouri, Feline Genetics and Comparative Medicine Laboratory

The overall goal of the laboratory is to bring Precision / Genomic Medicine to Companion Animals to improve the health of animals and humans. Research focuses on the genetic aspects of domestic cats, including inherited diseases as biomedical models for humans, cat phenotypic and morphological traits, and cat population dynamics, which are relevant to genetic disease studies, translational medicine, genetic testing, and forensic applications. Dr. Lyons also conducts studies on wild felids of all species in conjunction with the North American Felid Taxonomic Advisory Group and is a member of the SEC Tigers United Project. For more information: https://cvm.missouri.edu/research/feline-genetics-and-comparative-medicine-laboratory/

Supporting Translational Health Research: Implications of Feline Genotyping for Humans

EveryCat has a history of funding research that has translational medicine implications, as discoveries made for feline health can also cross over into treatments for humans. While the goal has always been to improve the lives of cats and the people who care for them, the research has also led to discoveries that reach far beyond feline medicine. Research funded by EveryCat has contributed to a better understanding of coronaviruses, including those related to COVID-19; has helped scientists uncover how genetics influences certain cancers across species; and has laid a foundation for the study of hypertrophic cardiomyopathy in humans.

About EveryCat Health Foundation

EveryCat Health Foundation, a non-profit organization established in 1968, advances feline health by supporting groundbreaking research and education. Its work worldwide has funded $12 million in cat health research studies at more than 30 partner institutions. Efforts are made possible through the generosity of dedicated donors and collaborators. Research funded by EveryCat Health Foundation helps veterinarians by providing groundbreaking insights to improve the diagnosis, treatment, and prevention of common feline health problems. Grants are awarded at least twice yearly with the help of the foundation's expert review panel. For further information or to support feline health research, please visit http://www.everycat.org.

Media Contact

Jackie Ott Jaakola, EveryCat Health Foundation, 1 (201) 275-0624, [email protected], http://www.everycat.org

Pam R Abrahamsson, PRA Public Relations, 1 5032989749, [email protected], www.prapublicrelations.com

SOURCE EveryCat Health Foundation

Modal title

EveryCat Health Foundation provides funding for University of Missouri College of Veterinary Medicine's 99 Lives Cat Genome Sequencing Initiative
EveryCat Health Foundation provides funding for University of Missouri College of Veterinary Medicine's 99 Lives Cat Genome Sequencing Initiative
EveryCat Health Foundation provides funding for University of Missouri College of Veterinary Medicine's 99 Lives Cat Genome Sequencing Initiative

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.